breakthrough
crystal
bacteri
leucin
transport
protein
leut
first
avail
xray
structur
neurotransmittersodium
symport
famili
develop
comput
model
suddenli
essenti
structurefunct
studi
plasmalemm
monoamin
transport
mat
leutbas
mat
model
use
guid
elucid
substrat
inhibitor
bind
pocket
molecular
dynam
simul
use
model
provid
insight
conform
involv
substrat
transloc
cycl
credibl
mat
model
final
hand
structurebas
virtual
screen
novel
ligand
yield
lead
compound
toward
develop
new
medic
psychostimul
depend
attent
deficit
hyperact
depress
anxieti
schizophrenia
disord
associ
dopamin
norepinephrin
serotonin
dysregul
monoamin
transport
mat
integr
mainten
neurotransmitt
homeostasi
respons
synapt
reuptak
chemic
messeng
termin
neurotransmiss
event
mat
member
protein
famili
also
includ
gaba
transport
glycin
transport
extens
review
famili
recent
publish
monoamin
neurotransmitt
imbal
link
drug
depend
mood
abnorm
neurolog
disord
given
involv
dopamin
norepinephrin
serotonin
numer
diseas
state
advanc
understand
mat
structur
function
regul
remain
prioriti
field
wait
two
decad
sinc
public
cdna
encod
mat
protein
reliabl
silico
virtual
mat
model
predict
ligand
bind
site
structur
aspect
could
inform
bench
experiment
review
focus
mat
protein
comput
advanc
follow
elucid
xray
structur
mat
homolog
leut
leucin
transport
aquifex
aeolicu
thermophil
bacterium
common
undersea
volcan
vent
univers
serv
templat
silico
mat
model
design
prior
avail
relev
crystal
structur
templat
mat
comput
effort
ligandbas
studi
focus
quantit
structureact
relationship
pharmacophor
gener
ligandbas
model
reli
establish
mat
ligand
associ
sar
provid
predict
power
studi
ligandtransport
interact
caveat
exist
ligandbas
studi
includ
assumpt
train
set
compound
experiment
establish
ligand
given
mat
bind
site
protein
similar
conform
addit
model
reli
biolog
data
merci
experiment
variat
eg
labtolab
cell
type
radioligand
displac
follow
crystal
leut
reliabl
homolog
model
mat
rapidli
surfac
prove
invalu
studi
transport
structur
function
mat
model
guid
elucid
ligand
bind
site
interand
intramolecular
interact
substrat
transloc
pathway
potenti
mat
conform
recent
structurebas
virtual
screen
vs
effort
identifi
put
ligand
novel
scaffold
serv
develop
mat
probe
lead
compound
drug
discoveri
electron
supplementari
materi
onlin
version
articl
contain
supplementari
materi
avail
author
user
brief
overview
evolut
current
state
util
mat
comput
model
develop
leut
crystal
structurebas
mat
model
first
discuss
follow
predict
mat
substrat
inhibitor
ion
cofactor
bind
pocket
md
simul
regard
substrat
transloc
mat
conform
structurebas
vs
toward
discoveri
novel
mat
ligand
lead
compound
therapeut
attempt
develop
mat
protein
model
prior
avail
leut
crystal
structur
discuss
due
uncertainti
model
xray
structur
nhaa
laci
later
found
adequ
resembl
mat
leut
protein
crystal
structur
provid
first
reliabl
mat
templat
comput
studi
leut
distant
bona
fide
mat
homolog
approxim
primari
amino
acid
sequenc
ident
supplementari
figur
leut
crystal
structur
reveal
invert
symmetri
tm
tm
tm
proxim
substrateion
permeat
pore
ligand
bind
site
tm
tm
unwound
approxim
midpoint
near
center
lipid
bilay
creat
primari
substrat
bind
pocket
na
bind
site
access
substrat
bind
site
control
tm
ionic
tm
hydrophob
bridg
compris
extracellularfac
gate
ionic
pretm
loop
il
interact
form
intracellular
gate
fig
origin
leutleucin
cocryst
launch
wave
new
mat
model
continu
corrobor
biophys
studi
advent
leut
crystal
structur
numer
mat
homolog
model
built
qualiti
model
depend
msa
employ
develop
msa
use
leut
templat
protein
one
import
step
model
build
process
msa
gener
first
align
region
conserv
among
protein
make
use
avail
biolog
data
follow
align
nonconserv
region
sever
mat
model
base
comprehens
align
nss
protein
supplementari
figur
tm
domain
cylind
symmetr
invert
motif
triangl
b
represent
hsert
base
leut
crystal
structur
primari
substrat
bind
site
repres
serotonin
magenta
flank
gate
residu
extracellular
green
yellow
intracellular
peach
side
c
leut
mat
gate
residu
colorcod
match
b
evolutionarili
conserv
region
nss
protein
primarili
locat
tm
domain
nontransmembran
extracellular
intracellular
connect
loop
less
conserv
nand
ctermin
tail
highli
sequencevari
nss
substrat
bind
pocket
predict
within
substrateion
transloc
pore
form
highli
conserv
region
tm
domain
supplementari
figur
mat
homolog
model
construct
use
msa
combin
templat
crystal
structur
model
refin
iter
endeavor
employ
initi
valid
includ
ramachandran
fold
analys
detail
regard
construct
dat
net
sert
model
publish
date
includ
tabl
ii
iii
respect
first
leutbas
dat
model
focus
substrat
interact
transport
substrat
permeat
pathway
dopamin
postul
favor
dat
locat
analog
leucin
bind
site
leut
free
energi
calcul
propos
bind
mode
dopamin
dat
close
agreement
experiment
valu
next
report
dat
model
use
dock
dopamin
damphetamin
two
nonoverlap
substrat
pocket
identifi
addit
previous
identifi
dopamin
bind
site
correspond
leucin
site
leut
put
second
site
locat
extracellular
vestibul
mat
region
extracellular
side
origin
dopamin
bind
site
extracellular
gate
keep
origin
leutleucin
crystal
structur
gate
close
dat
model
propos
vestibular
site
could
serv
temporari
stage
area
dopamin
upon
open
gate
dopamin
would
progress
along
permeat
pathway
interior
bind
site
correspond
leucin
leut
separ
work
leut
crystal
combin
h
leucin
bind
pharmacolog
appear
confirm
presenc
interior
vestibular
substrat
pocket
leut
second
substrat
molecul
must
occupi
vestibular
site
trigger
releas
first
substrat
molecul
primari
interior
site
cytoplasm
primari
secondari
substrat
site
label
respect
fig
leut
sert
necess
second
substrat
bind
site
challeng
crystal
structur
reveal
vestibular
site
may
occupi
inhibitor
ligand
certain
deterg
molecul
xray
snapshot
two
substrat
molecul
simultan
occupi
observ
case
essenti
aspect
mat
structurefunct
research
comput
model
net
lag
behind
dat
sert
given
similar
dat
net
polypeptid
sequenc
leutbas
dat
model
use
templat
construct
net
model
norepinephrin
found
dock
site
two
distinct
bind
pocket
identifi
nolan
tl
unpublish
use
net
model
base
opentoout
leut
crystal
structur
adapt
poissonboltzmann
solver
apb
calcul
select
dock
pose
establish
net
ligand
compar
experiment
data
secondari
substrat
bind
site
suggest
extracellular
vestibul
fig
three
mat
sert
receiv
comput
attent
sert
model
ligand
bind
pocket
consist
residu
tm
correspond
leucin
bind
site
leut
found
use
icm
pocket
finder
import
substrat
recognit
similar
conclus
reach
studi
leut
sert
substrat
bind
site
compar
suggest
larger
serotonin
substrat
may
accommod
smaller
sert
side
chain
present
rel
leut
presenc
sert
tm
aspart
residu
may
import
substrat
interact
pair
mutantligand
analog
complement
method
also
use
studi
bind
serotonin
sert
site
use
inducedfit
method
serotonin
analog
dock
three
independ
gener
hsert
model
pose
experiment
analyz
character
sert
point
mutant
respect
bind
serotonin
analog
interact
serotonin
residu
suggest
altern
orient
serotonin
suggest
mutagenesi
model
data
human
drosophila
sert
model
built
support
vector
machin
svm
model
deriv
experiment
bind
inhibit
data
serotonin
analog
hsert
dsert
identifi
differ
confer
speci
select
favor
pose
support
svm
model
mutagenesi
data
orient
serotonin
indol
nitrogen
toward
intracellular
side
bilay
near
hsert
dsert
residu
extracellularfac
gate
compar
serotonin
orient
suggest
separ
comput
work
final
dat
net
sert
model
dock
cognat
monoamin
substrat
yield
pose
suggest
differ
altern
substrat
bind
orient
ionic
mode
atom
pair
tm
aspart
hsert
substrat
align
catechol
hydroxyl
dopamin
norepinephrin
indol
hydroxyl
serotonin
term
chelat
mode
ionic
mode
monoaminemat
interact
wide
accept
experiment
evid
chelat
mode
sever
report
leut
crystal
structur
contain
inhibitor
bound
extracellular
vestibul
region
site
unless
otherwis
specifi
mat
model
discuss
herein
base
origin
leutleucin
crystal
structur
although
outward
extracellular
face
leut
xray
structur
access
extracellular
vestibul
presenc
substrat
molecul
pocket
render
occlud
conform
dock
cocain
leutbas
dat
model
result
cocain
bind
pocket
perhap
extracellular
gate
close
manual
open
gate
rotat
side
chain
away
substrat
permeat
pore
allow
cocain
sink
deeper
bilay
modest
encroach
pocket
unpublish
data
use
molecular
dynam
md
similar
cocain
bind
site
within
dat
obtain
author
conclud
dopamin
cocain
favor
inform
provid
nonoverlap
bind
site
propos
cocain
bind
pocket
impair
substrat
transport
block
pathway
use
steer
md
dat
model
base
msa
amphetamin
well
analog
tropanebas
inhibitor
cocain
benztropin
observ
reach
fig
ligandaccess
region
sert
region
avail
ligand
yellow
cyan
pocket
display
surfac
select
residu
defin
pocket
display
stick
atomtyp
color
clariti
main
tm
contributor
sert
ligand
bind
pocket
highlight
tm
pink
tm
green
tm
gold
tm
brown
el
blue
fig
leutbas
net
comput
model
yellow
surfac
cyan
surfac
bind
site
net
gray
shown
occupi
norepinephrin
yellow
nisoxetin
cyan
respect
bind
site
residu
atomtyp
line
extracellular
gateform
residu
atomtyp
stick
shown
interact
gate
residu
separ
pocket
pocket
access
inhibitor
verifi
pharmacolog
presenc
zn
ion
engin
dat
bind
site
extracellular
side
abl
trap
cocain
benztropin
analog
within
author
conclud
singl
dopamineoverlap
bind
site
exist
cocain
subsequ
work
result
similar
conclus
benztropin
analog
dat
model
base
leut
crystal
contain
tca
desipramin
use
examin
bind
bival
phenethylamin
dock
studi
suggest
larg
flexibl
compound
span
core
protein
simultan
occupi
pocket
dat
mutant
indic
bival
compound
prefer
inwardfac
conform
multipl
lowaffin
substrat
interact
site
propos
exist
throughout
transloc
pore
studi
focus
defin
drug
interact
mat
electrostat
potenti
surfac
dat
calcul
follow
dock
cocain
clomipramin
site
respect
recent
focu
norepinephrin
reuptak
inhibitor
nri
norepinephrinedopamin
reuptak
inhibitor
therapeut
attent
net
expect
increas
leutbas
net
homolog
model
creat
visual
effect
sitedirect
mutat
bind
desipramin
snail
venom
conopeptid
noncompetit
netselect
inhibitor
sever
residu
import
bind
locat
extracellular
vestibul
combin
net
model
dock
mutagenesi
led
conclus
bind
site
desipramin
conotoxin
overlap
conotoxin
substrat
site
fulli
separ
size
bulk
conopeptid
residu
peptid
two
intramolecular
disulfid
bridg
probabl
restrict
access
region
except
vestibul
separ
work
cocain
analog
found
dock
net
pocket
phenyl
group
dangl
extracellular
gate
salt
bridg
posit
essenti
coincid
tca
bind
site
base
dock
studi
mutat
gener
net
correspond
dat
shown
increas
sensit
net
reciproc
mutat
dat
decreas
sensit
similar
previou
dat
studi
author
conclud
cocain
occupi
net
bind
site
distinct
substrat
site
note
howev
site
occupi
norepinephrin
dock
experi
bind
tca
sert
studi
use
sert
model
base
opentoout
leut
crystal
structur
ligand
dock
analysi
agreement
sitedirect
mutagenesi
data
suggest
presenc
vestibular
lowaffin
tca
bind
site
dock
pose
posit
tricycl
ring
floor
vestibular
pocket
amin
tail
potenti
extend
site
regard
ssri
ligand
opentoout
occlud
leut
xray
structur
employ
develop
sert
dock
pose
ssri
ligand
appear
bind
high
affin
region
base
report
sever
group
unpublish
result
laboratori
sert
mutat
region
appreci
effect
ssri
bind
high
affin
senantiom
citalopram
escitalopram
thu
dock
site
sert
point
mutat
creat
experiment
test
pose
suggest
escitalopram
occup
mutat
sert
residu
previous
unassoci
ligand
bind
produc
signific
affin
chang
propos
critic
escitalopram
bind
structur
determin
confer
inhibitor
select
sert
net
also
address
use
ssri
citalopram
nri
talopram
respect
mutat
data
suggest
ssri
bind
pocket
overlap
substrat
pocket
wherea
talopram
bound
separ
site
structurebas
comput
effort
difficult
ion
cofactor
mat
substrat
inhibitor
mani
potenti
interact
site
ion
placement
na
cl
ion
mat
model
therefor
especi
reliant
leut
data
residu
interact
two
bound
na
ion
leut
crystal
structur
conserv
among
nss
protein
mat
investig
manual
place
na
ion
leutcorrespond
posit
dat
posit
leut
net
sert
given
two
protein
appear
need
one
na
ion
substrat
transloc
contrast
less
known
bind
domain
cl
ion
essenti
leut
nss
member
includ
tnat
hypothes
neg
charg
leut
residu
could
serv
role
cl
mat
eleg
studi
use
multiconform
continuum
electrostat
method
calcul
pk
membraneburi
acid
residu
neg
charg
side
chain
leut
replac
chargeneutr
residu
cl
depend
transport
serin
mat
protein
identifi
candid
clsurrog
cl
ion
incorpor
sert
model
posit
correl
leut
ion
coordin
hydroxyl
amin
hydrogen
tm
tm
tm
locat
cl
within
suggest
cl
posit
stabil
bind
na
fig
experiment
substitut
sert
chargeneutr
side
chain
decreas
transport
increas
k
cl
substitut
neg
charg
side
chain
howev
produc
cl
transport
albeit
reduc
activ
similar
studi
gaba
transport
agreement
respect
locat
cl
bind
site
suggest
cl
ion
precis
posit
tm
neg
charg
residu
surrog
requir
transport
addit
sert
tm
residu
coordin
cl
ion
appear
restrict
ion
flux
observ
serotoninna
cl
stoichiometri
like
mechan
substrat
transloc
across
lipid
bilay
via
altern
access
model
open
extracellularand
intracellularfac
gate
mat
altern
fashion
substrat
cotransport
ion
admit
briefli
held
inner
chamber
essenti
pocket
releas
travel
side
plasma
membran
one
two
gate
alway
close
uncontrol
ion
flux
across
pore
lipid
bilay
avoid
ion
gradient
key
drive
substrat
transport
retain
least
three
mat
conform
requir
outwardfac
extracellular
gate
open
substrateocclud
gate
close
trap
substrat
inwardfac
intracellular
gate
open
fig
dat
md
simul
absenc
presenc
dopamin
perform
studi
substrat
passag
protein
dopamin
bind
affin
evalu
use
mmpbsa
calcul
kcalmol
found
similar
experiment
bind
energi
kcalmol
substrat
permeat
appear
involv
format
breakag
extracellular
gate
salt
bridg
separ
md
work
corrobor
import
dat
extracellular
salt
bridg
format
leut
extracellular
gate
actual
promot
presenc
substrat
dat
salt
bridg
less
like
intact
differ
leut
dat
movement
unwind
also
identifi
dat
substrat
transloc
pathway
also
studi
use
steer
molecular
dynam
approach
dopamin
place
pull
extracellular
intracellular
direct
identifi
temporari
bind
event
site
correspond
simultan
dopamin
occup
trigger
passag
dopamin
cytoplasm
role
conserv
dat
residu
substrat
transloc
cycl
examin
use
free
energi
perturb
fep
phosphoacceptor
site
retw
consensu
sequenc
replac
aspart
mimic
phosphothreonin
side
chain
fep
simul
dat
mutant
favor
inwardfac
conform
experiment
support
find
indic
posttransl
modif
ntermin
tail
affect
dat
conform
sert
recognit
inhibitor
anxiolyt
buspiron
address
use
two
hsert
model
base
templat
repres
differ
conform
specif
outwardfac
leut
use
along
inwardfac
laci
due
lack
inwardfac
leut
crystal
structur
leut
recent
crystal
inwardfac
conform
dock
buspiron
analog
leutbas
model
suggest
two
discret
bind
site
correspond
term
site
postul
repres
highand
lowaffin
bind
fig
virtual
screen
novel
mat
ligand
structur
divers
hit
compound
identifi
larg
structur
databas
use
ligandbas
structurebas
vs
approach
hybrid
approach
ligandbas
method
employ
pharmacophor
model
exampl
contain
five
featur
label
volum
constraint
shown
structurebas
method
involv
dock
vs
compound
bind
site
orang
vdw
sphere
mat
homolog
model
hybrid
approach
structurebas
vs
usual
follow
ligandbas
vs
mode
respect
md
simul
perform
lacybas
model
effort
identifi
potenti
sert
conform
state
anoth
studi
md
trajectori
analysi
use
detect
movement
sert
residu
substrat
ion
transloc
upper
extracellularproxim
half
contain
key
residu
cl
bind
experienc
movement
md
find
experiment
test
use
scan
cystein
access
mutagenesi
identifi
solventexpos
residu
vacat
region
postul
allow
rotat
expos
permeat
pathway
md
simul
also
indic
sert
conform
rearrang
respons
serotonin
citalopram
bind
specif
extern
gate
residu
shown
adopt
differ
conform
accommod
chang
pocket
result
ligand
bind
md
simul
mutagenesi
laboratori
indic
import
residu
bind
serotonin
citalopram
deriv
md
comparison
unoccupi
serotoninbound
escitaloprambound
sert
indic
format
breakag
ionic
interact
substrat
transloc
discuss
dat
ntermin
tail
also
investig
influenc
sert
conform
use
md
simul
model
wildtyp
sert
differ
respect
access
inward
cytoplasm
face
side
sert
lack
phosphoryl
potenti
posit
favor
inwardfac
conform
reduc
substrat
turnov
amphetamineinduc
serotonin
efflux
unexpectedli
introduc
phosphat
mimic
posit
via
mutat
fail
preserv
amphetamineinduc
efflux
final
intrigu
studi
employ
extend
md
simul
track
sert
conform
function
substrateion
occup
bind
one
serotonin
molecul
trigger
sert
conform
shift
outwardfac
inwardfac
follow
intracellular
solvat
pocket
releas
cytoplasm
substrat
seen
solvat
intracellular
side
transloc
cell
substrat
occup
found
unnecessari
substrat
transport
util
mat
homolog
model
limit
mechanist
bind
studi
recent
report
demonstr
valu
use
model
identif
novel
chemotyp
fig
report
describ
discoveri
novel
mat
ligand
structurebas
vs
combin
dat
pocket
structur
base
pharmacophor
highthroughput
vs
chemic
databas
contain
compound
ten
compound
select
pharmacolog
evalu
base
score
affin
dg
moe
predict
pk
visual
inspect
commerci
avail
ifenprodil
analog
tabl
iv
discov
affin
three
mat
similar
approach
sert
util
fourfeatur
pharmacophor
span
pocket
halogen
bind
pocket
screen
subset
zinc
databas
two
structur
novel
select
sert
ligand
obtain
addit
sert
model
use
suggest
potenti
modif
vs
hit
compound
specif
dock
flexibl
align
studi
guid
hittolead
optim
nonselect
mat
inhibitor
discov
dat
virtual
screen
effort
novel
ssri
recent
databas
contain
avail
drug
kegg
drug
screen
use
pocket
leutbas
net
model
ten
topscor
drug
shown
inhibit
net
function
micromolar
level
therebi
provid
exampl
potenti
drug
repurpos
abil
uncov
new
drugact
profil
via
virtual
screen
furthermor
virtual
screen
studi
emphas
reliabl
leutbas
mat
model
effort
led
discoveri
micromolar
affin
hit
identifi
vs
hit
compound
use
homolog
model
crystal
structur
alway
guarante
moreov
compound
discov
vs
use
homolog
model
typic
character
low
micromolar
affin
recent
success
virtual
screen
use
mat
model
suggest
method
may
also
use
appli
protein
famili
given
famili
similar
elucid
leut
crystal
structur
breakthrough
monoamin
transport
research
serv
templat
gener
mat
protein
model
use
model
structurebas
comput
tool
novel
mat
ligand
discov
insight
protein
structur
aspect
ligand
recognit
gain
detail
dynam
natur
includ
conform
state
possibl
mechan
transport
protein
uncov
longstand
question
variou
structur
class
inhibitor
bind
mat
central
focu
mani
comput
studi
defin
conform
involv
substrat
transloc
cycl
actual
mechan
transloc
occur
also
matter
debat
whether
two
substrat
molecul
requir
transloc
cycl
structurebas
vs
effort
mat
model
reveal
ligand
novel
chemotyp
identif
could
like
achiev
via
comput
approach
hittolead
optim
chemotyp
lead
superior
cn
medic
display
fewer
advers
effect
